J&J CEO Won't Take Stand In Risperdal Breast-Growth Trial

Law360, Philadelphia (September 20, 2012, 7:32 PM EDT) -- Johnson & Johnson CEO Alex Gorsky will not be forced to take the stand in a trial set to begin Monday alleging a boy developed breasts after being treated with the antipsychotic drug Risperdal, a Pennsylvania state judge ruled Thursday.

Judge Arnold New of the Philadelphia Court of Common Pleas granted a motion from J&J division Janssen Pharmaceuticals Inc., agreeing to quash a subpoena directed at Gorsky by attorneys for the teenage plaintiff.

The teenager’s case, one of more than 80 pending in the court, accuses...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.